How Personalization and Supply Chain Efficiency are Driving Retail Resurgence

Designed for retail leaders and lovers alike, Retail Refined explores the in-store technology of the future, challenges the industry’s preconceived notions, and brings together retail’s biggest names to understand the brand strategies that will define the next decade in retail.

 

Melissa Gonzalez, host of MarketScale’s Retail Refined, knows what’s at the top of everyone in the industry’s mind as 2021 dawns – more personalized experiences and better supply chain efficiency.

In the wake of the COVID-19 pandemic, these two trends are paramount. Consumers are still hesitant to shop in person in many cases but, when they do, they’ll likely return to elevated expectations for personalized and tailored experiences. Those experience also transfer to online shopping, where data and analytics can help find ways to cater to individual consumers engaging in eCommerce.

More pressing on the backend of retail operations, though, is the need to find ways to ensure the supply chain keeps pace with all of this innovation.

To dive further into personalization and optimization of the supply chain, Gonzalez invited Paul Burel, Senior Consultant within Fujitsu America’s Consumer and Commercial Industries Group, onto the show to share his insights.

Prior to joining Fujitsu, Burel held several senior management roles in Store Operations and IT at Home Depot. He is also a consulting engineer with extensive experience in retail store design and construction andcomes from a family retail business that owned and operated grocery, hardware and convenience stores.

“A lot of conversations we’re having as we’re relooking at store design are about how we make these environments as agile and modular as possible, so they can flex as needed throughout key times of the year,” Burel said. “It’s a lot to think through, for sure, with all these technology integrations. I think one of the silver linings is all the learnings that we can garner, and I think that there’s a much more concerted effort within brands and retailers to understand that data and take actionable steps based on that. I think it also helps the ability to deliver upon personalization and really being able to map out customer journeys and offerings to satisfy what different consumers are looking for.”

Listen to Previous Episodes of Retail Refined Right Here!

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More